Publication | Open Access
Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy
91
Citations
19
References
2012
Year
Advanced Lung DiseaseMedicineStandard ChemotherapyImmunologySmoking Related Lung DiseaseAdvanced Lung AdenocarcinomaBronchial NeoplasmImmune Checkpoint InhibitorSurrogate MarkerOncologyRadiation OncologyLung Cancer
| Year | Citations | |
|---|---|---|
1981 | 7.8K | |
2002 | 4.9K | |
2002 | 3.7K | |
2011 | 1.3K | |
2002 | 890 | |
2000 | 594 | |
2008 | 564 | |
2011 | 556 | |
2011 | 471 | |
2007 | 461 |
Page 1
Page 1